Maintaining bone formation in microgravity/weightless environments remains a major challenge. In weightlessness, osteocytes act as mechanosensors to inhibit Wnt canonical signaling and bone formation by secreting sclerostin. This study explores… Click to show full abstract
Maintaining bone formation in microgravity/weightless environments remains a major challenge. In weightlessness, osteocytes act as mechanosensors to inhibit Wnt canonical signaling and bone formation by secreting sclerostin. This study explores whether osteocytic Wnt7b can counteract microgravity-induced bone loss through Wnt non-canonical signaling. Unlike previous bioprinting focusing on structural scaffolds or generic cell types, a novel bioprinted scaffold consisting of polycaprolactone (supportive) and osteocyte (functional) hydrogels was constructed. Osteocytes overexpressing Wnt7b were co-cultured with bone marrow stromal cells (ST2) in a 3D biomimetic weightless bio-microenvironmental system (3D-BWBM) to assess osteogenic and lipogenic differentiation. The results showed that osteocytic Wnt7b enhanced osteogenic differentiation and mineralization of ST2 cells via the Wnt non-canonical pathway PKCδ, while suppressing the expression of lipogenic markers (Pparg, Cebpa) and adipogenesis. RT-qPCR analysis showed elevated expression of Sost and Mef2C, down-regulation of the Wnt target gene Opg, and elevated expression of pro-osteoclastogenic cytokine RANKL and pro-inflammatory cytokines TNFα and IL-1β, thus validating the microgravity effect. Unlike conventional 2D culture of RCCS™ cells, the 3D hydrogels were printed with tunnels (500 μm) for efficient nutrient/metabolite exchange, resulting in good cell growth, high cell viability (97%), and a 6-fold increase in proliferative activity within 7 days. Wnt7b osteocytes were still able to maintain the osteogenic differentiation of ST2 cells as evidenced by elevated alkaline phosphatase activity, mineralization (1.8-fold increase), and a decrease in osteoblast marker genes (Alpl, Runx2, Col1a1). In conclusion, Wnt7b-PCKδ signaling counteracts microgravity-induced bone loss, and future in vivo osteocytic Wnt7b studies will confirm this causal relationship.
               
Click one of the above tabs to view related content.